Kawasaki Gakuen discovers new TM4SF1 and TMEM132b inhibitors
Nov. 4, 2022
Kawasaki Gakuen has divulged pyrrole-imidazole polyamides acting as transmembrane 4 L6 family member 1 (TM4SF1) and TMEM132b expression inhibitors reported to be useful for the treatment of cancer metastasis.